We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stool-Based DNA Testing Leads to Timely Colonoscopy

By LabMedica International staff writers
Posted on 15 Oct 2025

Colorectal cancer (CRC) remains a leading cause of cancer deaths in the US, yet many patients delay colonoscopy due to hesitancy and long wait times. More...

Long follow-up intervals after stool-based testing could further exacerbate health disparities in rural patients who already face significant barriers to health care. Now, a new observational study has shown that stool-based DNA testing can provide timely follow-up for both rural and urban patients and thus help increase equitable CRC screening.

The observational case–control analysis by researchers from the University of North Dakota (Grand Forks, ND, USA) included 1316 patients 18 years or older who had a positive DNA-based stool test and subsequently underwent diagnostic colonoscopy between January 2018 and December 2023. Participants were categorized as rural or nonrural using Rural-Urban Commuting Area codes, and the primary outcome was days from a positive stool test to diagnostic colonoscopy.

Of the 1,316 patients included, 668 (50.8% were classified as rural; the median time to diagnostic colonoscopy was similar between groups — 35 days for rural patients versus 37 days for nonrural patients (P=.6). Rural patients were significantly more likely to have their colonoscopy performed at an external facility (25% vs 3.1%; P<.001), despite comparable timeliness. In their research published in The American Surgeon, the authors note limitations, including reliance on recorded data and that the analysis focused only on patients who completed both stool testing and colonoscopy.

The investigators concluded that the findings support stool-based DNA testing as a tool to increase screening access and deliver timely diagnostic follow-up across geographic settings. At the study institution, the results informed plans to use stool-based testing for all low-risk patients, helping to stratify who needs diagnostic colonoscopy versus ongoing noninvasive monitoring. Broader adoption of stool-based testing could reduce missed diagnoses, shorten time to treatment, and help close rural–urban screening gaps.

“With all patients receiving colonoscopy in our system, patients had an average wait time of 1 year from initial contact to colonoscopy,” wrote the researchers. “It is also more accessible for many patients and helps stratify low-risk individuals, identifying those who require diagnostic colonoscopy vs. those who can be adequately monitored with stool-based testing alone.”


New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Gold Member
Hybrid Pipette
SWITCH
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.